Updated 3h ago

Top News

verasidfhaosidhsodih / vegconomist_de:

The Good Food Institute Europe reports €1.3 billion invested in alternative protein research in Europe from 2020 to 2025.

Between 2020 and 2025, European funders invested a total of €1.3 billion in alternative protein research, with €236 million allocated in 2025 alone. Germany ranks third in absolute public investment at €79 million since 2020, but tenth on a per capita basis with less than €1 per person invested.

Shauna Golden / nosh:

Barry Callebaut launches ChoViva cocoa-free chocolate alternative in North America.

At the Sweets & Snacks Expo 2026, Barry Callebaut showcased ChoViva, a cocoa-free chocolate alternative designed to deliver a chocolate-like experience using sunflower seeds instead of cocoa beans. The US launch of ChoViva comes after years of volatile cocoa pricing and supply as climate pressures and crop disease disrupted production in key growing regions.

Bill Wilson / supermarket_news:

Target sued in federal court over labeling of yogurt-covered snack products

A customer filed a class-action lawsuit in New York federal court alleging Target labels certain Favorite Day and Good & Gather products as yogurt-covered even though the coatings contain no yogurt or yogurt-based ingredients. The complaint cites items including Favorite Day Blueberry Yogurt Covered Mini Pretzels.

Thomas West / food_manufacture:

Finsbury Food Group launches officially licensed England and Scotland World Cup cupcakes in Tesco

Crafted in collaboration with the Football Association and the Scottish Football Association, the cupcakes will capitalise on the inevitable patriotic fervour that will arise this summer. Finsbury Food Group’s cupcakes will grace Tesco bakery aisles from 1 June, shortly ahead of the tournament’s opening match on 11 June, with an RRP of £6.00 per pack.

Nikki Hancocks / nutraingredients:

Qina launches Food Health Ecosystem to improve access to real-world data

The platform aims to address what founder Mariette Abrahams described as a lack of real-world and long-term data, high consumer costs, low adherence and underutilized user data. Abrahams said the rise of GLP-1 drugs has created an opportunity to innovate in personalized nutrition using long-term behavioral and dietary insights.